These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1971122)

  • 1. [Pharmacologic bases of antihypertensive drugs with mechanisms of multi-factor action].
    Van Zwieten PA
    Therapie; 1990; 45 Suppl 2():177-82. PubMed ID: 1971122
    [No Abstract]   [Full Text] [Related]  

  • 2. An antihypertensive drug with polyfactor mechanism of action: urapidil.
    Van Zwieten PA; Prichard BN
    Ann Fr Anesth Reanim; 1989; 8(5):568-71, 528-31. PubMed ID: 2627052
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihypertensive drugs: proposed sites and mechanisms of action.
    Kaplan HR; Smith RD
    Fed Proc; 1981 Jun; 40(8):2268-74. PubMed ID: 6113170
    [No Abstract]   [Full Text] [Related]  

  • 4. Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients?
    Doyle AE
    J Hypertens Suppl; 1988 Dec; 6(2):S51-3. PubMed ID: 2906701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity.
    van Zwieten PA; Blauw GJ; van Brummelen P
    Drugs; 1990; 40 Suppl 4():1-8; discussion 28-30. PubMed ID: 1982649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic pharmacology of alpha-adrenoceptor antagonists and hybrid drugs.
    van Zwieten PA
    J Hypertens Suppl; 1988 Dec; 6(2):S3-11. PubMed ID: 2906698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive mode of action of ketanserin.
    Robertson JI; Stott DJ; Ball SG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S45-7. PubMed ID: 2446069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alpha 1 receptors and blood pressure control. Mechanisms of hypotensive action of urapidil?].
    Brisac AM
    Therapie; 1990; 45 Suppl 2():187-90. PubMed ID: 2160131
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacology, efficacy and safety of a new alpha 1 adrenoceptor antagonist with an additional central action, in hypertension.
    Man in 't Veld AJ
    Eur Heart J; 1992 Jun; 13 Suppl A():58-60. PubMed ID: 1356778
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W; Müller-Wieland D; Nägele H; Behnke B; Greten H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of ketanserin or urapidil on haemodynamics, stress response and kidney function during operations for myocardial revascularisation.
    Petry A; Wulf H; Baumgärtel M
    Anaesthesia; 1995 Apr; 50(4):312-6. PubMed ID: 7747847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new antihypertensive: ketanserin].
    Salvini P
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):77-84. PubMed ID: 2678304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketanserin: systemic and regional hemodynamic characterization of its serotonergic and alpha-adrenergic receptor blocking effects in the pithed SHR.
    Scalbert E; Richer C; Giudicelli JF
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):94-104. PubMed ID: 2468942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW; Lebel W; Weeks R
    J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardiovascular and autonomic properties of N-phenylpiperazine (NPP) in several animal models.
    Cohen MR; Hinsch E; Palkoski Z; Vergona R; Urbano S; Sztokalo J
    J Pharmacol Exp Ther; 1982 Oct; 223(1):110-9. PubMed ID: 6126578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of the antihypertensive effects of ketanserin: a comparison with metoprolol.
    Casiglia E; Gava R; Semplicini A; Nicolin P; Pessina AC
    Br J Clin Pharmacol; 1986 Dec; 22(6):751-2. PubMed ID: 2882774
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
    Goering J; Zimmerman BG
    J Pharmacol Exp Ther; 1986 May; 237(2):553-7. PubMed ID: 2871176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action site of ketanserin enhancing baroreflex function is within the rostral ventrolateral medulla in anesthetized rats.
    Fu YJ; Wang WZ; Cai GJ; Wang MW; Su DF
    Auton Neurosci; 2006 Jan; 124(1-2):31-7. PubMed ID: 16344003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol.
    Brizzi A; Brizzi V; Valoti M
    Farmaco; 2005 Feb; 60(2):105-11. PubMed ID: 15752469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats.
    Balasubramaniam G; Lee HS; Mah SC
    J Pharmacol Exp Ther; 1993 Jan; 264(1):129-34. PubMed ID: 8093720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.